Review ArticleReviewsR
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC
SILVANA GIACINTI, GIULIA POTI, MICHELA ROBERTO, SERENA MACRINI, MARIA BASSANELLI, FRANCESCA DI PIETRO, ANNA MARIA ASCHELTER, ANNA CERIBELLI, ENZO MARIA RUGGERI and PAOLO MARCHETTI
Anticancer Research November 2018, 38 (11) 6029-6039; DOI: https://doi.org/10.21873/anticanres.12953
SILVANA GIACINTI
1Belcolle Hospital ASL Viterbo, Viterbo, Italy
GIULIA POTI
2Sapienza University of Rome, Rome, Italy
MICHELA ROBERTO
2Sapienza University of Rome, Rome, Italy
SERENA MACRINI
2Sapienza University of Rome, Rome, Italy
MARIA BASSANELLI
3San Camillo Del Lellis Hospital ASL Rieti, Rieti, Italy
FRANCESCA DI PIETRO
2Sapienza University of Rome, Rome, Italy
ANNA MARIA ASCHELTER
4Sant'Andrea Hospital of Rome, Rome, Italy
ANNA CERIBELLI
3San Camillo Del Lellis Hospital ASL Rieti, Rieti, Italy
ENZO MARIA RUGGERI
1Belcolle Hospital ASL Viterbo, Viterbo, Italy
PAOLO MARCHETTI
2Sapienza University of Rome, Rome, Italy
In this issue
Anticancer Research
Vol. 38, Issue 11
November 2018
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC
SILVANA GIACINTI, GIULIA POTI, MICHELA ROBERTO, SERENA MACRINI, MARIA BASSANELLI, FRANCESCA DI PIETRO, ANNA MARIA ASCHELTER, ANNA CERIBELLI, ENZO MARIA RUGGERI, PAOLO MARCHETTI
Anticancer Research Nov 2018, 38 (11) 6029-6039; DOI: 10.21873/anticanres.12953
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC
SILVANA GIACINTI, GIULIA POTI, MICHELA ROBERTO, SERENA MACRINI, MARIA BASSANELLI, FRANCESCA DI PIETRO, ANNA MARIA ASCHELTER, ANNA CERIBELLI, ENZO MARIA RUGGERI, PAOLO MARCHETTI
Anticancer Research Nov 2018, 38 (11) 6029-6039; DOI: 10.21873/anticanres.12953
Jump to section
- Article
- Abstract
- Taxanes: Mechanism of Action
- Tubulin Alteration
- Kinesins
- Multidrug Resistance Phenotype
- ERG and TMPRSS2-ERG Fusion Gene
- Growth Factor, Apoptosis Regulators, and Intracellular Pathways
- Epithelial-to-mesenchimal Transition (EMT)
- Cytokines and Inflammation
- AR Receptor Variants in Taxane Sensitivity
- AR Mutation and Expression of Constitutively Active AR-variants
- Non-genomic AR Resistance
- New Treatment Strategies Focus on Non-genomic Resistance
- New Treatment Strategies Focus on Suppressing AR Activity
- The Future of Targeted Therapies and Precision Cancer Care
- Footnotes
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- MicroRNA-like snoRNA-derived RNAs (sdRNAs) promote castration resistant prostate cancer
- Enzalutamide-induced Proteolytic Degradation of the Androgen Receptor in Prostate Cancer Cells Is Mediated Only to a Limited Extent by the Proteasome System
- Blockade of {gamma}-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells